Literature DB >> 12590901

Statin effects beyond lipid lowering--are they clinically relevant?

P O Bonetti1, L O Lerman, C Napoli, A Lerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12590901     DOI： 10.1016/s0195-668x(02)00419-0

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  112 in total

Review 1.  Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Authors:  Yasushi Matsuzawa; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

2.  Endothelial function and cerebrovascular disease: implications for diagnosis and treatment.

Authors:  Ahmad A Elesber; Piero O Bonetti; Amir Lerman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

3.  The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention.

Authors:  Jessica M Ma; Cynthia A Jackevicius; Uchenwa Genus; Vladimir Dzavik
Journal:  Can J Cardiol       Date:  2006-04       Impact factor: 5.223

Review 4.  Isoprenoid metabolism and the pleiotropic effects of statins.

Authors:  Ulrich Laufs; James K Liao
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 5.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

6.  Long-standing statin therapy and the risk of new-onset diabetes in the elderly: collateral damage caused by preventive medicine?

Authors:  Luca Mascitelli; Mark R Goldstein
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

Review 7.  Statins and their role in pre-percutaneous coronary intervention.

Authors:  Rosetta Melfi; Annunziata Nusca; Giuseppe Patti; Germano Di Sciascio
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

Review 8.  Radiation as a risk factor for cardiovascular disease.

Authors:  John E Baker; John E Moulder; John W Hopewell
Journal:  Antioxid Redox Signal       Date:  2011-03-23       Impact factor: 8.401

9.  Time-dependent degenerative transformations in the lipidome of chalazia.

Authors:  Jadwiga C Wojtowicz; Igor A Butovich; Anne McMahon; Robert N Hogan; Kamel M Itani; Ronald Mancini; Mike Molai; Emily Linsenbardt
Journal:  Exp Eye Res       Date:  2014-08-19       Impact factor: 3.467

10.  Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Authors:  Michel P Hermans; Jean-Charles Fruchart
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.